SEC Form 4 · accession 0000899243-19-000269
Solid Biosciences Inc. · SLDB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Juan Andrey Zarur
Director
Period of report
Jan 2, 2019
Accepted (ET)
Jan 3, 2019 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001707502
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy)F1 | $28.92 | Jan 2, 2019 | A | 10,000 | A | — | Jan 2, 2029 | Common Stock | 10,000 | 10,000 | D |
| Director Stock Option (Right to Buy)F2 | $28.92 | Jan 2, 2019 | A | 100,000 | A | — | Jan 2, 2029 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1This option was granted on January 2, 2019 and vests in full on the one year anniversary of the grant date.
- F2This option was granted on January 2, 2019 and vests in four equal consecutive annual installments beginning January 2, 2020.